ECSP993197A - AQUEOUS DRUG FORMULATION FOR ORAL ADMINISTRATION (CASE LEA 32857-EC) - Google Patents

AQUEOUS DRUG FORMULATION FOR ORAL ADMINISTRATION (CASE LEA 32857-EC)

Info

Publication number
ECSP993197A
ECSP993197A ECSP993197A ECSP993197A EC SP993197 A ECSP993197 A EC SP993197A EC SP993197 A ECSP993197 A EC SP993197A EC SP993197 A ECSP993197 A EC SP993197A
Authority
EC
Ecuador
Prior art keywords
lea
case
oral administration
drug formulation
aqueous drug
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Hans-Martin Siefert
Tobias Laich
Annette Simon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP993197 priority Critical patent/ECSP993197A/en
Publication of ECSP993197A publication Critical patent/ECSP993197A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica acuosa para uso oral que comprende un principio activo de la clase de los antibióticos ácidos quinolón o naftiridoncarboxilicos asi como al menos un ácido policarboxílico o una sal del mismo expandibles, a un procediento para su preparación asi como al uso de la misma para la fabricación de un medicamento.The present invention relates to an aqueous pharmaceutical composition for oral use comprising an active ingredient from the class of quinolone or naphthyridonecarboxylic acid antibiotics as well as at least one expandable polycarboxylic acid or salt thereof, to a process for its preparation as well as to the use of the same for the manufacture of a medicine.

ECSP993197 1999-10-29 1999-10-29 AQUEOUS DRUG FORMULATION FOR ORAL ADMINISTRATION (CASE LEA 32857-EC) ECSP993197A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP993197 ECSP993197A (en) 1999-10-29 1999-10-29 AQUEOUS DRUG FORMULATION FOR ORAL ADMINISTRATION (CASE LEA 32857-EC)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP993197 ECSP993197A (en) 1999-10-29 1999-10-29 AQUEOUS DRUG FORMULATION FOR ORAL ADMINISTRATION (CASE LEA 32857-EC)

Publications (1)

Publication Number Publication Date
ECSP993197A true ECSP993197A (en) 2000-01-27

Family

ID=42044186

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP993197 ECSP993197A (en) 1999-10-29 1999-10-29 AQUEOUS DRUG FORMULATION FOR ORAL ADMINISTRATION (CASE LEA 32857-EC)

Country Status (1)

Country Link
EC (1) ECSP993197A (en)

Similar Documents

Publication Publication Date Title
DE69906518D1 (en) DRUG DISPENSING SYSTEM CONTAINS A SOLID, SOLID, DRY-BASED BASIS
NZ631100A (en) Soft chewable pharmaceutical products
AR006678A1 (en) DERIVATIVES OF TRICYCLIC MACROLIDES, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM, USE OF THEM TO PREPARE MEDICINES AND PROCEDURE FOR THEIR PREPARATION
CR7362A (en) PHARMACEUTICAL FORMULATIONS OF PLATINUM DERIVATIVE
BRPI0015567B8 (en) compound, pharmaceutical composition, dosage unit form, use of the pharmaceutical composition and method for preparing a pharmaceutical composition
MX2010004222A (en) Solid formulations of crystalline compounds.
HUP0302131A2 (en) Pharmaceutical tramadol salts, pharmaceutical compositions containing them
BRPI0611400B8 (en) Muco-adhesive xyloglycan-containing formulations useful in medical devices and pharmaceutical formulations
ECSP083351A (en) PHARMACEUTICAL COMPOSITIONS
CO5060477A1 (en) DOSAGE FORM OF NEFAZODONA
BR0312563A (en) Lasofoxifene tablet and its coating
DE60313359D1 (en) FENOFIBRATEDIC PHARMACEUTICAL COMPOSITION AND ITS PHYSIOLOGICALLY COMPATIBLE SALTS AND DERIVATIVES
UY29561A1 (en) DERIVATIVES OF QUINAZOLINE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCEDURES AND APPLICATIONS
AR044200A1 (en) COMPOSITION OF FONDAPARINUX SODICO DE HIGH PURITY, A PROCEDURE FOR THE PREPARATION OF THIS COMPOSITION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT AS AN ACTIVE PRINCIPLE
AR013967A1 (en) A DRUG FORMULATION FOR ORAL ADMINISTRATION OF CONTROLLED PELLET PELLET THAT HAS CONTROLLED RELEASE OF AN ACTIVE COMPOUND THAT IS SELECTED FROM THE ACID 1-CYCLOPROPIL-7- [(S, S) -2,8-DIAZABICICLO [4.3.0] NON- 8-IL] -6-FLUOR-1,4-DIHIDRO-8-METOXI-4-OXO-3-CARBOXILIC QUINOLON OR SALE
PH12022550430A1 (en) Pharmaceutical formulations comprising sodium palmitoyl-l-prolyl-l-prolyl-glycyl-l-tyrosinate and methods for preparing the same
HRP20050342B1 (en) OLANZAPINE PHARMACEUTICAL FORMULATION
EE200200143A (en) Bile benzylaminoquinoline conjugates with bile acid and their hetero analogs, process for their preparation, drugs containing these compounds and their use
AR002972A1 (en) PILLS THAT HAVE A PHARMACEUTICAL MATRIX THAT PROVIDE AN APPROPRIATE PROFILE OF DRUG RELEASE, COMPOSITION FOR THE PREPARATION OF SAID PILLS, PROCESS FOR PREPARING SUCH PILLS AND DOSAGE FORMS OF SUCH COMPOSITION.
AR024411A1 (en) POLYMORPHES OF A CRYSTALLINE DICLORHYDRATE OF AZOBICICLO [2.2.2] OCT-3-ILAMINE AND ITS PHARMACEUTICAL COMPOSITIONS.
TR200301553A1 (en) New oral pharmaceutical formulations containing irbesartan active ingredient
HN1999000174A (en) ACUISA MEDICATION FORMULATION FOR ORAL ADMINISTRATION.
EA200601015A1 (en) ORAL COMPOSITIONS OF DEOXYPEGANINE AND THEIR APPLICATION
CY1113140T1 (en) STRONG ORAL FORM OF THE ORAL, CONTAINING THE ANTI-PETAIL FACTOR, AND A METHOD OF PREPARATION
GT200000087A (en) POLYMORPH FORMS OF A AZABICICLO CITRATE (2.2.2) OCTAN - 3 - AMINA AND ITS PHARMACEUTICAL COMPOSITIONS.